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ABSTRACT
Objective To assess the prevalence, location, presentation 
and consistency of conflict of interest statements in oral 
presentations at medical conferences
Design Prospective, delegate-based observational study
Sample 201 oral presentations at 5 medical conferences 
in 2016
Main outcome measures Presence of a conflict of 
interest statement, its location within the presentation 
and its duration of display. Concordance between conflict 
of interest disclosures in oral presentations and written 
abstracts or meeting speaker information
Results Conflict of interest statements were present 
in 143/201 (71%) presentations (range for conferences 
26%–100%). 118 of the 141 evaluable statements (84%) 
were reported on a specific slide. Slides containing conflict 
of interest statements were displayed for a median (IQR) 
2 s (1–5), range for conferences 1.25–7.5 s. Duration of 
display was shorter when the slide contained only the 
conflict of interest statement, 2 s (1–3.5), than when 
it contained other information, 8 s (3–17), but was not 
affected by type of presentation or whether a conflict of 
interest was disclosed. When a conflict of interest was 
disclosed, 27/84 (32%) presenters discussed an aspect 
of it. Discordance between the presence of a conflict of 
interest disclosure in the oral presentation and written 
formats occurred for 22% of presentations.
Conclusion In oral presentations at the medical 
conferences we assessed, conflict of interest statements 
were often missing, displayed too briefly to be read and 
understood, or not discussed/explained by the presenter. 
They were sometimes discordant with statements in the 
corresponding written formats. Conference delegates’ 
ability to assess the objectivity and quality of the 
information in oral presentations may therefore have been 
diminished.
InTRODuCTIOn
Conflicts of interest (COIs) can compromise 
the integrity and objectivity of professional 
opinions, distort the interpretation of clinical 
research and erode public trust.1 Disclosure 
of COIs is widely promoted within academia, 
regarded as ‘an essential, though limited’ 
step in addressing the issue of potential bias.2 
It permits the recipients of medical research 
findings and educational presentations to 
consider the potential for the competing 
interest(s) to influence the content and tone 
of the presentation.
Medical conferences are common, highly 
influential vehicles for informing and 
educating health practitioners: as many as 
100 000 may be held worldwide annually.3 
Attendance contributes substantially to 
continuing medical education for many dele-
gates. Oral presentations attract large audi-
ences, and giving an oral presentation confers 
academic prestige. Commercial interest 
and involvement in medical conferences is 
strong, leading to concerns that such entities 
may have undue influence over programme 
content and faculty.3 4 In this setting, clear 
disclosure of COIs of presenters is important.
To date, limited research has been 
conducted on disclosure of COIs by speakers 
at medical conferences. In two disciplines, 
orthopaedics and oncology, COI disclosure 
was inconsistent5 and fleeting.6 We evalu-
ated the prevalence, duration, presentation 
and consistency of COI disclosure in oral 
presentations at two international and three 
national conferences we attended in 2016. 
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Strengths and limitations of this study
 ► An analysis of conflict of  interest reporting at 
medical conferences in which data collection was 
undertaken in ‘real-time’ by delegate investigators.
 ► Conferences sampled spanned five medical 
disciplines, but may not be generalisable to all 
disciplines.
 ► The sample of conferences and presentations 
was determined pragmatically, based on the 
investigators’ academic interests, not randomly 
selected.
 ► The study methodology did not permit an analysis of 
content of conflict of interest disclosure.
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Our study was designed to evaluate these outcomes in 
‘real-time’ from a delegate’s perspective.
MeThODS
Medical conferences
Four investigators conducted the assessments at five 
conferences in 2016: the US Endocrine Society (AG), 
the American College of Rheumatology (ND), the UK 
Continence Society (FS), the UK Congress on Obesity 
(AA), and Heart UK (AA). Our sample of conferences 
was pragmatic, being determined by our clinical or 
academic interests. Session attendance was also deter-
mined by investigators’ interests, but all oral presenta-
tions attended were evaluated. Two conferences, those 
convened by the US Endocrine Society and the American 
College of Rheumatology, provided speakers with instruc-
tions about both the requirement for COI disclosure and 
its location within the presentation, the others did not. At 
one conference, the American College of Rheumatology, 
a meeting official screened presentations on site for the 
presence of a COI statement. Presentations were catego-
rised as review or plenary (≥30 min), original research 
standard (10–15 min) or short (3 min), or other.
Data collection
Our study was conducted in real time. A single investi-
gator gathered data at each conference. At each oral 
presentation assessed, the investigator sat with a clear, 
unobstructed view of the projection screen, and in a 
location at which the presentation was clearly audible, 
and completed a standardised spreadsheet (see online 
supplementary appendix).
Outcomes
Main outcomes were the presence of a COI statement, 
its location within the presentation and its duration of 
display. Duration of display of the COI was estimated by 
the sotto voce conversational recital of ‘one elephant, two 
elephant…’ for the duration of the display, where each 
‘elephant’ approximates 1 s.7
For each presentation, we also extracted COI informa-
tion from the written abstract or speaker information in 
the conference programme, if either was available.
We recorded whether each presenter specifically 
discussed any aspect of a COI disclosure. If a presenter 
simply stated ‘These are my disclosures/conflicts of 
interest’, we did not code it as discussing the COI. We 
recorded whether the tone adopted to discuss a COI was 
serious or jokey/dismissive, as a subjective observation. 
We recorded examples of noteworthy terminology used 
by presenters in discussing COI disclosures.
Statistics
The composition and size of our sample of presenta-
tions were pragmatically determined by the structure of 
the contributing conferences and the interests of the 
delegate investigators. We report descriptive statistics as 
proportions or median (IQR). Comparisons between 
groups were made using the Mann-Whitney U test.
Patient involvement
Patients were not involved in the design or conduct of 
this study.
Because ours was an observational study in public 
where participants are not identified, ethical approval was 
not required.
ReSulTS
We evaluated 201 presentations—79 reviews, 119 original 
research (93 standard, 26 short) and 3 patient perspec-
tives (table 1). One hundred and forty-three presentations 
(71%) included a COI statement (range for conferences 
26%–100%). For two presentations (one American 
College of Rheumatology, one UK Continence Society), it 
was not recorded whether a COI was disclosed. For three 
presentations (one US Endocrine Society, one UK Conti-
nence Society, one UK Congress on Obesity), duration of 
display of the COI statement was not recorded. Among 
the 141 evaluable presentations that included a COI state-
ment, 84 (60%) disclosed at least 1 COI and 118 (84%) 
reported the COI on a slide that only contained the COI 
(range for conferences 45%–100%).
Disclosure of COIs in oral presentations
Figure 1 shows the duration of display of slides containing 
the COI statements. Overall, the median (IQR) duration 
of display of slides containing the COI statements was 2 s 
(1–5). The median duration of display varied from 1.25 s 
to 7.5 s at individual conferences. Figure 2 shows the rela-
tionships between duration of display and three poten-
tial modifiers. Duration of display of the COI statement 
was shorter when the statement was on a specific slide, 
2 s (1–3.5), n=117, than when it was on a slide containing 
other information, 8 s (3–17), n=23, p<0.0001. It was 
similar in the presentations that disclosed at least one 
COI, 2 s (1–6), n=83, and the presentations that disclosed 
no COI, 2 s (1–4), n=55, p=0.13. It was similar in review/
plenary presentations, 2 s (1–5.3), n=50, and in other 
presentations, 2 s (1–5.3), n=90, p=0.42.
Because of the very brief duration of display of most 
of the COI statements, we were rarely able to accurately 
count the number of individual COIs disclosed, or to 
discern their nature or relevance. Neither were our 
delegate investigators able to reliably ascertain whether 
COI statements referred to only the presenter or to the 
presenter and coauthors. In 27/84 (32%) presentations 
that contained a COI statement and disclosed at least 
one COI, the speaker explicitly discussed an aspect of it. 
When such an explicit discussion was undertaken, its tone 
was dismissive or jokey in 9/27 (33%) of instances (box).
Comparison of COI statements in oral and written formats
Table 2 shows data on the relationships between COI state-
ments in oral presentations and their corresponding 
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Table 1 Characteristics of conferences, oral presentations and COI statements
Conference
COI disclosure 
guidance provided
Presentations 
assessed
n
COI statement 
included
n/n (%)
COI statement on 
its own slide
n/n (%)
At least one COI 
disclosed
n/n (%)
US Endocrine 
Society
Yes* 64 54/64 (84%) 51/54† (94%) 33/54 (61%)
American College of 
Rheumatology
Yes*‡ 45 45/45 (100%) 45/45 (100%) 26/44§ (59%)
UK Continence 
Society
No 43 31/43 (72%) 14/31† (45%) 12/30§ (40%)
UK Congress on 
Obesity
No 26 7/26 (27%) 4/7¶ (57%) 7/7 (100%)
Heart UK No 23 6/23 (26%) 4/6¶ (67%) 6/6 (100%)
Total 201 143/201 (71%) 118/143 (83%) 84/141 (60%)
*COI statement should be on second slide of presentation.
†Remaining COI statements were on title slides.
‡Meeting representative checked presentations for compliance with presence and location of COI statement.
§Not recorded for one presentation.
¶Remaining COI statements were on title slide or conclusion slide.
COI, conflict of interest.
Figure 1 Duration of display of slides containing conflict 
of interest statements in oral presentations at medical 
conferences. Data are median, IQR and range. ACR, 
American College of Rheumatology; UKCO, UK Congress on 
Obesity; UKCS, UK Continence Society; US Endo Society, 
US Endocrine Society. 
Figure 2 Duration of display of slides containing conflict 
of interest statements in oral presentations at medical 
conferences. Data are median, IQR and range. COI, conflict 
of interest. 
written formats (abstracts or meeting speaker infor-
mation). For 192/201 presentations, there was a corre-
sponding written abstract and/or speaker information in 
either the online or hard copy conference programme. 
For three conferences, the UK Continence Society, the 
UK Congress on Obesity, and Heart UK, no COI state-
ments were available for any of the meeting abstracts 
(n=93) in their written formats. Therefore, in only 99 
of 192 (52%) presentations was there a COI statement 
in both oral and written formats. For these 99 presenta-
tions, we found discordance for the presence of a COI 
disclosure between the oral and written formats in 22 
cases (22%) (figure 3). A COI disclosure was found in the 
oral but not the written format in 17 of the 22 discordant 
cases, and in the written but not the oral format in 5 of 
the 22 discordant cases. The proportions of presentations 
discordant for the presence of a COI disclosure and of 
discordance attributable to absence of a COI disclosure 
in each format were similar at each evaluable conference.
DISCuSSIOn
Main findings
In our sample, 29% of oral presentations at medical 
conferences did not include a COI statement, and there-
fore did not comply with recommendations that COI 
disclosure be undertaken in academic discourse.2 When 
present, COI statements were often displayed too briefly 
to read, let alone understand. Although the duration of 
display of a COI statement might be influenced by time 
constraints for the presentation, it was similarly brief in 
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Box 1 examples of dismissive or jokey approaches to 
discussing conflict of interest disclosure
‘[Company X] have funded me to do disease state talks and the 
creativity of the company has been appreciated.’
‘Here are my potential conflicts of interest: I've been very bad (pointing 
to list of commercial conflicts) and very lucky (pointing to grant 
funding).’
‘These are my disclosures, none are particularly relevant.’ No 
explanatory statement.
‘Here are my conflicts. If you don't like them, I have more.’
‘I work with a lot of companies.’ Speaker claimed requirement for 
academic-industry ‘collaboration’ to ‘help our patients’, did not explain 
nature of multiple listed conflicts of interest.
‘I'll come back to these later,’ but did not do so.
Table 2 COI and disclosures in oral presentations and 
meeting programme*
Conference
Oral presentations 
with 
corresponding 
written abstract 
or speaker 
information
N
COI statement 
present in both 
oral presentation 
and written 
abstract 
or speaker 
information
N/N (%)
US Endocrine 
Society
64 54/64 (84%)
American College 
of Rheumatology
45 45/45 (100%)
UK Continence 
Society
43 0/43 (0%)
UK Congress on 
Obesity
19† 0/19 (0%)
Heart UK 21‡ 0/21 (0%)
Total 192 99/192 (52%)
*Written presentation abstract or speaker faculty information.
†For seven presentations, neither written abstract nor speaker 
information was available.
‡For two presentations, neither written abstract nor speaker 
information was available.
COI, conflict of interest.
Figure 3 Discordance in the presence of COI statements 
between oral presentations at medical conferences and the 
corresponding written formats (written abstract or speaker 
information). No oral presentations at the other conferences 
had conflict of interest statements present in both oral 
presentations and the corresponding written formats. ACR, 
American College of Rheumatology; COI, conflict of interest; 
US Endo Society, US Endocrine Society.
longer review presentations and shorter original research 
presentations. The longer duration of display of COI state-
ments when they were presented on slides that contained 
other information suggests that the other information 
was responsible for the longer display. Speakers seldom 
discussed or explained any aspect of their disclosed COIs, 
and sometimes adopted a dismissive or frivolous tone 
when doing so. COI statements were not present in 48% 
of the written formats corresponding to oral presenta-
tions. When COI statements were present in both oral 
presentations and the corresponding written formats, 
discordance in the presence of a COI disclosure between 
oral and written formats occurred in 22% of cases.
limitations
Although our study assessed presentations at meetings 
spanning five disciplines, our results might not apply to 
other medical specialities. Collecting data in real time 
is both a strength, mimicking as closely as possible the 
experiences of conference delegates, and a limitation, 
because it precludes analysis of the nature and relevance 
of the COI. Data were collected for each oral presenta-
tion by a single investigator. We did not randomly select 
the presentations assessed, instead taking a pragmatic 
approach which is likely to approximate the behaviour of 
most conference delegates.
Context
Our study suggests delegates at medical conferences may 
be unable to accurately assess the potential influence of 
COI on the content and conclusions of oral presentations. 
This could occur because COI statements may frequently 
be absent, displayed too briefly to be read or not discussed 
in the context of the material being presented. Delegates 
who wish to obtain information about COIs relevant 
to oral presentations from the corresponding written 
formats may be thwarted by their absence from the latter, 
or misled because of inaccurate or discordant disclosures. 
Failure to achieve adequate communication of informa-
tion about COIs might impair the delegates’ ability to 
assess the value and quality of the information contained 
in the presentations. A systematic review reported that 
patients, physicians and participants in clinical research 
all considered that financial COIs compromised the 
quality of clinical care and research.8
We found that rates of inclusion of COI statements in 
presentations varied among conferences: higher rates 
were achieved when conference organisers provided 
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specific instructions and/or pursued policies to vet 
presentations for COI statements. However, these policies 
did not necessarily enhance the delegates’ knowledge 
or understanding of the COIs, because the duration of 
display of the COI statements in presentations at those 
conferences was as brief as that for the COI statements 
in the presentations at the conferences without specific 
policies designed to promote inclusion of COI state-
ments. Among conferences that did not provide instruc-
tions about COI statements, the UK Continence Society 
meeting achieved a higher rate of inclusion of statements. 
The reason for this is uncertain, but it might reflect height-
ened awareness of COIs arising from controversy about 
financial COIs over transvaginal mesh devices (personal 
communication, Emeritus Professor Cathryn Glazener).
We identified few studies similar to ours. However, 
Endo et al reported that only 72% of oral presentations 
at a dermatology conference included a COI statement, 
even after several strategies were applied to remind 
presenters of the requirement to do so.9 In addition, two 
studies reported display times of 3 and 5 s, respectively, 
for slides containing COI information at orthopaedic 
and oncology meetings, respectively.6 10 Finally, 9% of 
presenters who gave oral presentations at each of two 
conferences on arthroplasty in the same calendar year 
disclosed financial COIs at one meeting but not the 
other.11 Each of these results is broadly consistent with 
our findings, and suggests that the results we report apply 
generally across conferences in medical disciplines other 
than those we assessed.
COnCluSIOnS AnD IMPlICATIOnS
Our study suggests that management of COI at medical 
meetings may be suboptimal. To avoid paying lip service 
to COIs in conference presentations, improvements could 
be made in several areas and both conference organisers 
and presenters can contribute. Disclosure statements 
should be required and their presence audited. Efforts 
to standardise the content and focus of COI statements, 
such as those initiated by the Institute of Medicine,12 
should be supported and applied by conference organ-
isers. COI statements by presenters should be displayed 
long enough to permit understanding, and their rele-
vance adequately discussed. Innovative strategies such 
as displaying COI statements during question time, or 
having the session chairperson include a COI statement 
as part of the introduction of the presentation, could be 
trialled. Finally, presenters should explain any discor-
dance between the contents of disclosures in oral and 
written formats.
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